Angiodynamics Inc. (ANGO)
Market Open
1 Sep, 17:35
$
15. 83
-0.3
-1.8332%
$
655.12M Market Cap
- P/E Ratio
- Div Yield
90,140 Volume
-0.39 Eps
$ 16.13
Previous Close Want to track ANGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ANGO trading today lower at $15.83, a decrease of -1.8332% from yesterday's close, completing a monthly increase of 7.0609% or $1.04. Over the past 12 months, ANGO stock gained 23.0326%.
ANGO is not paying dividends to its shareholders.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.061%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
ANGO Chart
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock?
Zacks | 2 weeks ago
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
AngioDynamics NASDAQ: ANGO expects its MedTech business to become the majority of company revenue in fiscal 2027, as the company continues a multiyear shift away from slower-growth legacy markets and toward higher-growth medical technology platforms, executives said during a Canaccord fireside chat.
Marketbeat | 2 weeks ago
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
Zacks | 3 weeks ago
Angiodynamics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 157 | $1,753.69 | $2,322.03 | $568.34 | 32.41% |
 Curtis Ellergodt Rothschild Investment LLC | 40 | $513.64 | $604.4 | $90.76 | 17.67% |
| NA Nizar Araji National Bank Of Canada /FI/ | 4,998 | $56,827.26 | $78,418.62 | $21,591.36 | 37.99% |
| BG Bart Gancher Intech Investment Management LLC | 10,264 | $94,967.91 | $161,042.16 | $66,074.25 | 69.58% |
| KAC Kimberly A. Clarke Stoneridge Investment Partners LLC | 12,298 | $139,656.09 | $185,822.78 | $46,166.69 | 33.06% |
Angiodynamics Inc. (ANGO) FAQ
What is the stock price today?
The current price is $15.83.
On which exchange is it traded?
Angiodynamics Inc. is listed on NASDAQ (NGS).
What is its stock symbol?
The ticker symbol is ANGO.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 655.12M.
Has Angiodynamics Inc. ever had a stock split?
No, there has never been a stock split.
Angiodynamics Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | James C. Clemmer CEO | NASDAQ (NGS) Exchange | 03475V101 CUSIP |
| US Country | 632 Employees | - Last Dividend | - Last Split | 27 May 2004 IPO Date |
Overview
AngioDynamics, Inc. is a prominent provider of invasive medical devices, catering to the needs of professional healthcare providers across the United States and internationally. The company specializes in a broad spectrum of medical areas, including vascular access, surgery, peripheral vascular disease, and oncology. Established in 1988, AngioDynamics is committed to enhancing patient outcomes through its innovative technologies and solutions, headquartered in Latham, New York.
Products and Services
- Auryon Atherectomy System: A cutting-edge solution for the treatment of peripheral arterial disease. This system utilizes an optimized wavelength, pulse width, and amplitude to efficiently remove lesions while preserving the vessel wall endothelium.
- Thrombus Management Portfolio:
- AlphaVac System: A mechanical aspiration device designed for emergent situations, obviating the need for perfusionist support.
- Thrombolytic Catheters: These are used to deliver drugs known as thrombolytic agents, intended to dissolve blood clots found in hemodialysis access grafts, arteries, veins, and surgical bypass grafts.
- AngioVac Circuit: Designed for extracorporeal circulatory support for up to six hours. This includes a pump, filter, and reinfusion cannula to facilitate venous drainage during bypass procedures.
- NanoKnife IRE Ablation System: Offers a non-traditional thermal approach for the surgical ablation of soft tissue, providing an alternative to conventional methods.
- Peripheral Products: This category includes a range of products such as angiographic catheters, diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. These are essential tools for peripheral diagnostic and interventional procedures.
- Drainage Catheters: A diverse range of catheters for various purposes, including multi-purpose/general, nephrostomy, and biliary drainage.
- Micro Access Kits: Provides interventional physicians with a smaller introducer system for conducting minimally invasive procedures.
- VenaCure EVLT System: Utilized in endovascular laser procedures to treat superficial venous disease, showcasing the company's commitment to vascular health.
- Solero MTA System: Comprising the Solero microwave generator and specially designed Solero MW applicators, this system targets microwave thermal ablation processes.
Contact Information
Address: 14 Plaza Drive
Phone: 518 795 1400
Website: https://www.angiodynamics.com
